AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 101 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $0 | – | 100 | +100.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 50 | -50.0% | 0.00% | – |
Q4 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2015 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $2,000 | -33.3% | 100 | -33.3% | 0.00% | 0.0% |
Q4 2014 | $3,000 | -89.3% | 150 | -82.4% | 0.00% | -83.3% |
Q3 2014 | $28,000 | +3.7% | 850 | 0.0% | 0.01% | -57.1% |
Q2 2014 | $27,000 | – | 850 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |